Francis discusses the rapid advancements in genomic science, particularly during the pandemic, highlighting the rise of genomic epidemiology and mRNA vaccines. He emphasizes the shift from theoretical applications to real-world clinical uses, such as gene therapies and CRISPR. Entrepreneurs are encouraged to identify existing momentum in these fields to scale their impact effectively.
